Systematic Review and Meta–Analysis of the Diagnostic Accuracy of Fibrosis Marker Panels in Patients with HIV/Hepatitis C Coinfection

REFERENCES

• Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med. 2003;138(3):197–207.
   PubMed Web of Science ®Google Scholar
• Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology. 1999;30(4): 1054–1058.
   PubMed Web of Science ®Google Scholar
• Soto B, Sanchez-Quijano A, Rodrigo L, del OlmoJA, Garcia-Bengoechea M, Hernandez-Quero J, et al. Human immu-nodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J HepatoL 1997;26(1)1–5.
   Web of Science ®Google Scholar
• Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Rizza CR, Dusheiko GM, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Hae-mophilia Centre Directors' Organisation. Lancet. 1997; 350(9089):1425–1431.
   PubMed Web of Science ®Google Scholar
• Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analy-sis. Clin Infect Dis. 2001;33(4):562–569.
   PubMed Web of Science ®Google Scholar
• Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38(6): 1449–1457.
   PubMed Web of Science ®Google Scholar
• Friedman LS. Controversies in liver biopsy: who, where, when, how, why? Curr Gastroenterol Rep. 2004;6(1): 30–36.
   PubMedGoogle Scholar
• Churchill DR, Mann D, Coker RJ, Miller RF, Glazer G, Goldin RD, et al. Fatal haemorrhage following liver biopsy in patients with HIV infection. Genitourin Med. 1996;72(1): 62–64.
   PubMedGoogle Scholar
• Garcia-Ordonez MA, Colmenero JD, Jimenez-Onate F, Martos F, Martinez J, Juarez C. Diagnostic usefulness of percutaneous liver biopsy in HIV-infected patients with fever of unknown origin. J Infect. 1999;38(2):94–98.
   PubMed Web of Science ®Google Scholar
• Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J GastroenteroL 2004;99(6)1160–1174.
   Web of Science ®Google Scholar
• Zeremski M, Talal AH. Noninvasive markers of hepatic fi-brosis: are they ready for prime time in the management of HIV/HCV co-infected patients? J Hepatol. 2005;43(1):2–5.
   PubMed Web of Science ®Google Scholar
• Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol. 2006;44(3):462–474.
   PubMed Web of Science ®Google Scholar
• lmbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in pa-tients with hepatitis C virus infection: a prospective study. Lancet. 2001;357(9262)1 069–1075.
   PubMed Web of Science ®Google Scholar
• Fl-BROCHURE: The FibroTest-ActiTest-HCV FIBROSURE Investigator's Brochure. Available at: www.biopredictive.com Accessed November 13, 2006.
   Google Scholar
• Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–526.
   PubMed Web of Science ®Google Scholar
• Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002;36(4 Pt 1):986–992.
   PubMed Web of Science ®Google Scholar
• Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astern-borski J, Thomas DL, et al. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis mark-ers: the SHASTA index. J Hepatol. 2005;43(1):78–84.
   PubMed Web of Science ®Google Scholar
• Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. Br Med J. 1994;309(6964): 1286–1291.
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality as-sessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3: 25.
   Google Scholar
• Whiting P, Rutjes AW, Dinnes J, Reitsma J, Bossuyt PM, Kleijnen J. Development and validation of methods for as-sessing the quality of diagnostic accuracy studies. Health Technol Assess. 2004;8(25):iii, 1–234.
   Google Scholar
• Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1994;20(1 Pt 1):15–20.
   PubMed Web of Science ®Google Scholar
• Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepati-tis. J Hepatol. 1995;22(6):696–699.
   PubMed Web of Science ®Google Scholar
• Moses LE, Shapiro D, Littenberg B. Combining indepen-dent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional con-siderations. Stat Med. 1993;12(14):1293–1316.
   PubMed Web of Science ®Google Scholar
• Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med. 2002;21(9):1237–1256.
   PubMed Web of Science ®Google Scholar
• Dukic V, Gatsonis C. Meta-analysis of diagnostic test ac-curacy assessment studies with varying number of thresh-olds. Biometrics. 2003;59(4):936–946.
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Ra-diology. 1982;143(1):29–36.
   Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Cochrane WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–129.
   Web of Science ®Google Scholar
• Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test perfor-mance. J Clin Epidemiol. 2003;56(11):1129–1135.
   PubMed Web of Science ®Google Scholar
• Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A sys-tematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med. 2004;164(18): 1978–1984.
   Web of Science ®Google Scholar
• Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in di-agnostic reviews. J Clin Epidemiol. 2005;58(10):982–990.
   PubMed Web of Science ®Google Scholar
• Schmid CH, Stark PC, Berlin JA, Landais P, Lau J. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Eoidemiol. 2004;57(7):683–697.
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in system-atic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882–893.
   PubMed Web of Science ®Google Scholar
• Maor Y, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, et al. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy? Haemophilia. 2006;12(4):372–379.
   PubMed Web of Science ®Google Scholar
• Mohsen AH, Easterbrook PJ, Taylor C, Portmann B, Ku-lasegaram R, Murad S, et al. Impact of human immuno-deficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003; 52(7):1035–1040.
   PubMed Web of Science ®Google Scholar
• Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive in-dex to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–1325.
   PubMed Web of Science ®Google Scholar
• Al-Mohri H, Cooper C, Murphy T, Klein MB. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med. 2005;6(6):375–378.
   PubMed Web of Science ®Google Scholar
• Macias J, Giron-Gonzalez JA, Gonzalez-Serrano M, Merino D, Cano P, Mira JA, et al. Prediction of liver fibrosis in hu-man immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut 2006;55(3): 409–414.
   PubMed Web of Science ®Google Scholar
• Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, et al. HIV infection does not affect the performance of non-invasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr 2005;40(5):538–544.
   PubMed Web of Science ®Google Scholar
• Myers RP, Benhamou Y, Imbert-Bismut F, Thibault V, Bo-chet M, Charlotte F, et al. Serum biochemical markers ac-curately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS. 2003;17(5):721–725.
   PubMed Web of Science ®Google Scholar
• Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS. 2007;21(9): 1073–1089.
   PubMed Web of Science ®Google Scholar
• Poynard T, Munteanu M, lmbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al. Prospective analysis of dis-cordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem. 2004;50(8): 1344–1355.
   PubMed Web of Science ®Google Scholar
• Shaheen AA, Myers RP. Diagnostic accuracy of the aspar-tate aminotransferase-to-platelet ratio index for the pre-diction of hepatitis C-related fibrosis: a systematic review. Hepatology. 2007;46(3):912–921.
   PubMed Web of Science ®Google Scholar
• Halfon P, Bacq Y, De Muret A, Penaranda G, Bourliere M, Ouzan D, et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol. 2007;46(3):395–402.
   PubMed Web of Science ®Google Scholar
• Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12)1705–1713.
   Web of Science ®Google Scholar
• de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coin-fected patients. J Acquir Immune Defic Syndr 2006;41(2): 175–179.
   PubMed Web of Science ®Google Scholar